User profiles for M. Klinger

Marco Klinger

Università degli Studi di Milano, IRCCS Humanitas Research Hospital
Verified email at humanitas.it
Cited by 3461

Role of blood platelets in infection and inflammation

MHF Klinger, W Jelkmann - Journal of interferon & cytokine research, 2002 - liebertpub.com
Blood platelets are here presented as active players in antimicrobial host defense and the
induction of inflammation and tissue repair in addition to their participation in hemostasis. …

Adenosine receptors: G protein-mediated signalling and the role of accessory proteins

M Klinger, M Freissmuth, C Nanoff - Cellular signalling, 2002 - Elsevier
… are protein kinase A (PKA) and members of the nonreceptor tyrosine kinase family Src
because A 2A -dependent ERK activation can be blocked by appropriate inhibitors (Klinger M, …

Platelets and inflammation

MHF Klinger - Anatomy and embryology, 1997 - Springer
Besides their functions in the haemostatic process and in thrombus formation after an endothelial
injury, blood platelets also take part in the processes of inflammation and tissue repair …

[PDF][PDF] Multiple early factors anticipate post-acute COVID-19 sequelae

…, DH May, R Taniguchi, RM Gittelman, M Klinger… - Cell, 2022 - cell.com
Post-acute sequelae of COVID-19 (PASC) represent an emerging global crisis. However,
quantifiable risk factors for PASC and their biological associations are poorly resolved. We …

Tumor regression in cancer patients by very low doses of a T cell–engaging antibody

R Bargou, E Leo, G Zugmaier, M Klinger, M Goebeler… - Science, 2008 - science.org
… All seven patients treated at the recently completed dose level of 0.06 mg/m 2 showed … of
0.03 and 0.06 mg/m 2 per day. Blinatumomab doses of 0.015 mg/m 2 per day and higher led to …

[PDF][PDF] Targeted therapy with the T-cell–engaging antibody blinatumomab of chemotherapy-refractory minimal residual disease in B-lineage acute lymphoblastic …

…, N Gökbuget, M Goebeler, M Klinger… - Journal of clinical …, 2011 - researchgate.net
Purpose Blinatumomab, a bispecific single-chain antibody targeting the CD19 antigen, is a
member of a novel class of antibodies that redirect T cells for selective lysis of tumor cells. In …

Long-term follow-up of hematologic relapse-free survival in a phase 2 study of blinatumomab in patients with MRD in B-lineage ALL

…, E Degenhard, ME Goebeler, M Klinger… - Blood, The Journal …, 2012 - ashpublications.org
Persistence or recurrence of minimal residual disease (MRD) after chemotherapy results in
clinical relapse in patients with acute lymphoblastic leukemia (ALL). In a phase 2 trial of B-…

Immunopharmacologic response of patients with B-lineage acute lymphoblastic leukemia to continuous infusion of T cell–engaging CD19/CD3-bispecific BiTE …

M Klinger, C Brandl, G Zugmaier… - Blood, The Journal …, 2012 - ashpublications.org
… In this trial, blinatumomab was continuously infused to patients by a portable mini-pump
and port system at a dose level of 15 μg/m 2 /d for 4 weeks. Subsequent treatment cycles were …

Fat injection for cases of severe burn outcomes: a new perspective of scar remodeling and reduction

M Klinger, M Marazzi, D Vigo, M Torre - Aesthetic plastic surgery, 2008 - Springer
Background Despite civilization and progress, burns occur frequently in the world. Remarkable
discoveries of wound healing mechanisms have been reported. On the other hand, long-…

Cutting edge: neutrophil granulocyte serves as a vector for Leishmania entry into macrophages

G Van Zandbergen, M Klinger, A Mueller… - The Journal of …, 2004 - journals.aai.org
… MF were generated by culturing autologous monocytes for 2 days in complete RPMI 1640
medium supplemented with 10 ng/ml M-CSF (Peprotech). MF were coincubated with infected …